If I was to take your version of their plan it would make
If I was to take your version of their plan it would make me laugh. I don’t understand what they are thinking when they feel Long Haulers is going to be our first approval. It’s clearly Brazil Covid EUA’s and they are in another world if they can’t see this. It shows us all how out of touch these people really are. It really is sad that they can’t see their way around this company. Maybe they are remedial learners or maybe they just plainly don’t pay attention and see what is really happening. This gives me no trust in them at all. Never has.
What’s amazing is after a trial for Long Haulers there will be no EUA and they must feel there is a chance. This must be because the ivermectin prescriber says so. I am going to believe Ohm and what he has said about no chance we get a EUA for Long Haulers. No unmet medical need is the reason why.
So if we put these lost souls in charge and they go after Long Haulers first we wait a long time before this company receives any substantial revenue. BLA’s are 10 months out. Ol’ Closet said that when they take over they will stop all trials and just go after one indication at a time. How stupid does this sound? Is this the management you want to see in charge? I would not like to see this. I feel we can handle the small trials that we have going and it will pay off in time saved for a better performance of indications approved or label extensions for our platform drug. It just seems like they would come in and trip us up so we go bankrupt because they can’t find financing ( when we don’t need it with Brazil approvals) and will just try to bankrupt us so they can have that bankruptcy liquidation sale and sell IncellDX our Leronlimab for pennies on the dollar. If you’re wondering how I know this. I have been talking to a medium and this is what the Crystal ball says. The medium says we only have one chance and that is to not vote for them bastards and seal their fate from ever trying to run a biotech. Which by the way have no experience in doing. They are not an improvement at all and if you want chang… we need positive change not unknowing change with how terrible they can become.
13
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...
Continue Reading
King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...
Continue Reading
Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...
Continue Reading
Shedding Light on SUN ORB's Indoor Revolution Sometimes, the best ideas come from simple needs, like wanting a bit of sunshine in your life. That's the deal with this SUN ORB concept—an invention dreamed up by a chap from Oklahoma who's spent too much time away from the natural light outside. We're talking about a wellness-oriented lighting idea that has big ambitions...
Continue Reading
Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...
Continue Reading
When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...
Continue Reading
SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...
Continue Reading
Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...
Continue Reading
A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...
Continue Reading
Strengthening the Network: Patti Humble Joins EWA Seeing Patti Humble lace up her boots and march into the Exceptional Women Alliance (EWA) is like watching a seasoned chess master find her tournament. Over decades, Humble's built a reputation as a linchpin in the corporate finance world, weathering transformations, mergers, and industry shifts that'd make a lesser-known...
Continue Reading
Top 5 Most Recently Viewed Articles
Lanvin Group to Unveil 2024 Revenue Results Lanvin Group (NYSE: LANV), a prominent name in the luxury fashion industry, is gearing up to announce its preliminary revenues for 2024. The event will be significant for investors and market enthusiasts alike, as it will provide insights into the group’s growth trajectory and market positioning. Conference Call Scheduled for...
Continue Reading
New Insights in Heart Monitoring iRhythm Technologies, Inc. (NASDAQ: IRTC), has revealed pivotal findings through a significant study published in Heart Rhythm. This recent analysis highlights the importance and effectiveness of their Zio long-term continuous monitoring (LTCM) service over traditional monitoring methods, particularly addressing actionable arrhythmias in...
Continue Reading
Unveiling the Stanford Prison Experiment: A Deep Dive into Human Nature National Geographic has premiered an intriguing trailer for their upcoming docuseries, THE STANFORD PRISON EXPERIMENT: UNLOCKING THE TRUTH, set to air soon. This three-part series, directed by Juliette Eisner and produced by Muck Media, will provide insights into one of psychology's most notorious...
Continue Reading
SpringWorks Therapeutics Reflects on Fourth Quarter and 2024 Achievements SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a biopharmaceutical company dedicated to treating severe rare diseases and cancer, has reported strong preliminary fourth quarter and full year financial results for 2024. The company achieved notable U.S. net product revenues of $61.5 million in the...
Continue Reading
Frisco Economic Development Corporation Cultivates Venture Capital In an exciting development for the entrepreneurial landscape, the Frisco Economic Development Corporation (FEDC) has announced the appointment of Jon Nordby as the inaugural Venture Capitalist in-Residence (VCiR). This unique initiative is part of a larger four-pillar innovation strategy designed to...
Continue Reading